di-PST13-RK-K

General Information


DRACP ID  DRACP03635

Peptide Name   di-PST13-RK-K

Sequence  KKKFPWWWPFKKK,KKKFPWWWPFKKKK

Sequence Length  28

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C200H280N46O27

Absent amino acids  ACDEGHILMNQRSTVY

Common amino acids  K

Mass  424245

Pl  11.88

Basic residues  13

Acidic residues  0

Hydrophobic residues  10

Net charge  13

Boman Index  -4625

Hydrophobicity  -183.21

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  33000

Absorbance 280nm  1222.22

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 1

Title  Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  9315

DRACP is developed by Dr.Zheng's team.